首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1394004

北美結構心臟市場預測至 2028 年 - 區域分析 - 按產品、程序和最終用戶

North America Structural Heart Market Forecast to 2028 - Regional Analysis - by Product, Procedure, and End User

出版日期: 2023年10月10日 | 出版商:

The Insight Partners | 英文 133 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

北美結構心臟市場預計將從2022年的69.675億美元成長到2028年的112.0147億美元。預計2022年至2028年CAGR為8.2%。

創新結構心臟服務的可用性推動北美結構心臟市場

據世界衛生組織（WHO）稱，心血管疾病是全球第二大死因。因此，正在採取各種措施來控制心血管疾病。心臟瓣膜疾病預計是心臟衰竭最常見的原因之一。主動脈瓣和二尖瓣的退化性疾病以及三尖瓣功能障礙的疾病在嚴重的情況下會導致更嚴重的臨床病程。近年來，針對結構性心臟病的微創、外科手術和導管為基礎的干涉措施急劇增加。結構性心臟是一個不斷發展的領域，包括心臟瓣膜手術和經導管手術；因此，正在為心臟外科醫生和內科醫生安排各種培訓方案。在過去的十年中，結構性心臟病的發病率不斷上升，因此有必要製定正式的培訓計劃，以確保勞動力具備適當的能力。不同項目的培訓結構、長度和範圍差異很大。大多數項目提供經導管主動脈瓣置換術 (TAVR) 手術的紮實暴露，同時提供房間隔或室間隔缺損封堵、左心耳封堵和先天性心臟病干預的較少且可變的經驗。隨著 TAVR、MitraClip 二尖瓣修復系統（雅培血管）和左心耳封堵術 (LAAO) 手術的出現，用於治療複雜心血管疾病患者的結構性心臟手術數量顯著增加。許多組織已經以有組織的形式為結構性心臟計劃開發了服務和程序產品，以適應大量患者的湧入。總體而言，SHD 培訓令人興奮、富有挑戰性且回報豐厚。隨著該領域的發展，SHD 培訓的標準化對於確保患者護理的最佳品質變得極為重要。尋找一位導師來幫助解決概述的眾多注意事項可能是成功從培訓過渡到實踐的最佳資產。

北美結構心臟市場概況

北美結構性心臟市場預計從 2022 年到 2028 年將以 8.2% 的CAGR成長。推動市場成長的關鍵因素是創新的結構性心臟服務以及心血管疾病和培訓項目數量的增加。然而，高昂的手術成本以及有關結構心臟裝置的嚴格法規是阻礙市場成長的主要因素。

北美結構心臟市場收入及 2028 年預測（百萬美元）

北美結構心臟市場細分

北美結構心臟市場分為產品、程序、最終用戶和國家。

根據產品，北美結構性心臟市場分為封堵器、瓣環成形術環、心臟瓣膜球囊等。 2022 年，封堵器細分市場佔據北美結構心臟市場的最大佔有率。

依手術方式，北美結構性心臟市場分為心臟瓣膜狹窄、心臟瓣膜逆流和左心耳封堵術。 2022 年，心臟瓣膜狹窄細分市場在北美結構性心臟市場中佔據最大佔有率。

根據最終用戶，北美結構性心臟市場分為醫院、門診手術中心等。 2022 年，醫院細分市場在北美結構性心臟市場中佔據最大佔有率。

根據國家/地區，北美結構心臟市場分為美國、加拿大和墨西哥。 2022年，美國主導北美結構心臟市場。

雅培實驗室(Abbott Laboratories)、美敦力公司(Medtronic Plc)、波士頓科學公司(Boston Scientific Corp)、Artivion Inc、Edwards Lifesciences Corp、樂普醫療科技北京有限公司、Braile Biomedica Industry, Commerce and Representations Ltd 和Micro Interventional Devices Inc 是北美結構性醫療行業的一些領先公司。心臟市場。

市場促進因素
- 創新結構性心臟服務的可用性
- 心血管疾病病例和培訓計畫數量不斷增加
主要市場限制
- 程序成本高
- 關於結構心臟裝置的嚴格規定
主要市場機會
- 人工智慧在結構性心臟的應用越來越廣泛
未來的趨勢
- 結構性心臟器械領域的技術進步
影響分析

第 6 章：北美結構心臟市場 - 北美分析

北美結構心臟市場收入預測與分析

第 7 章：北美結構心臟市場 - 收入和 2028 年預測 - 按產品

概述
北美結構心臟市場收入佔有率，按產品 2021 年和 2028 年 (%)
封堵器
瓣環成形術環
心臟瓣膜氣球
其他

第 8 章：北美結構心臟市場 - 2028 年收入和預測 - 按程序

概述
北美結構心臟市場收入佔有率，按程序 2021 年和 2028 年 (%)
心臟瓣膜狹窄
心臟瓣膜逆流
左心耳封堵術

第 9 章：北美結構心臟市場 - 收入和 2028 年預測 - 按最終用戶

概述
2021 年和 2028 年北美結構心臟市場收入佔有率（按最終用戶分類）（%）
醫院
門診手術中心
心臟中心

第 10 章：北美結構心臟市場 - 2028 年收入與預測 - 國家分析

北美：北美結構心臟市場
- 概述

第 11 章：北美結構心臟市場 - 產業格局

概述
成長策略
- 概述

第 12 章：公司簡介

Abbott Laboratories
Medtronic Plc
Boston Scientific Corp
Artivion Inc
Edwards Lifesciences Corp
Lepu Medical Technology Beijing Co Ltd
Braile Biomedica Industry, Commerce and Representations Ltd
Micro Interventional Devices Inc

第 13 章：附錄

關於洞察合作夥伴
專業術語

簡介目錄圖表

Product Code: BMIRE00028946

The North America structural heart market is expected to grow from US$ 6,967.50 million in 2022 to US$ 11,201.47 million by 2028. It is estimated to grow at a CAGR of 8.2% from 2022 to 2028.

Availability of Innovative Structural Heart Services Fuel North America Structural Heart Market

According to the World Health Organization (WHO), cardiovascular diseases are the second leading cause of death worldwide. Therefore, various initiatives are being taken to control cardiovascular diseases. Heart valve disease is expected to be one of the most common causes of heart failure. Degenerative diseases of aortic and mitral valves, and diseases of dysfunctional tricuspid valves lead to a worse clinical course in severe cases. Minimally invasive, surgical, and catheter-based interventions for structural heart disease have increased dramatically recently. The structural heart is an evolving field consisting of heart valve surgeries and transcatheter procedures; therefore, various training programs are being arranged for cardiac surgeons and physicians. Over the past decade, the burgeoning incidence of structural heart disease has necessitated the development of formal training programs to ensure the appropriate competency of workforces. The structure, length, and scope of training vary greatly between programs. Most programs provide solid exposure on transcatheter aortic valve replacement (TAVR) procedures, simultaneously providing a lesser and variable experience of atrial septal or ventricular septal defect closure, left atrial appendage closure, and congenital heart defect interventions. With the advent of TAVR, the MitraClip mitral valve repair system (Abbott Vascular), and left atrial appendage occlusion (LAAO) procedures, there has been a significant increase in the volume of structural cardiac procedures performed for treating patients with complex cardiovascular conditions. Many organizations have developed services and procedural offerings in an organized format for the structural cardiac program to accommodate the influx of patients. Training in SHD is exciting, challenging, and rewarding overall. As the field evolves, standardization of SHD training becomes extremely important to ensure the best quality of patient care. Finding a mentor to help navigate the numerous considerations outlined can be the best asset to successfully transitioning from training to practice.

North America Structural Heart Market Overview

The North America Structural heart market is estimated to grow at a CAGR of 8.2% from 2022 to 2028. Key factors driving the market growth are innovative structural heart services and rise in the number of cardiovascular diseases and training programs. However, high cost of procedure followed by stringent regulations regarding structure heart device are the major factor hampering the growth of the market.

North America Structural Heart Market Revenue and Forecast to 2028 (US$ Million)

North America Structural Heart Market Segmentation

The North America structural heart market is segmented into product, procedure, end user, and country.

Based on product, the North America structural heart market is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held the largest share of the North America structural heart market in 2022.

Based on procedure, the North America structural heart market is segmented into heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. The heart valve stenosis segment held the largest share of the North America structural heart market in 2022.

Based on end user, the North America structural heart market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the North America structural heart market in 2022.

Based on country, the North America structural heart market is segmented into US, Canada, and Mexico. US dominated the North America structural heart market in 2022.

Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, Artivion Inc, Edwards Lifesciences Corp, Lepu Medical Technology Beijing Co Ltd, Braile Biomedica Industry, Commerce and Representations Ltd, and Micro Interventional Devices Inc are some of the leading companies operating in the North America structural heart market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America structural heart market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America structural heart market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Scope of the Study
1.2 Market Segmentation
- 1.2.1 North America Structural Heart Market - by Product
- 1.2.2 North America Structural Heart Market - by Procedure
- 1.2.3 North America Structural Heart Market - by End User
- 1.2.4 North America Structural Heart Market - by Country

2. North America Structural Heart Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Structural Heart Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
4.3 Expert's Opinion

5. North America Structural Heart Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Availability of Innovative Structural Heart Services
- 5.1.2 Rising Number of Cardiovascular Disease Cases and Training Programs
5.2 Key Market Restraints
- 5.2.1 High Cost of Procedures
- 5.2.2 Stringent Regulations Regarding Structure Heart Devices
5.3 Key Market Opportunities
- 5.3.1 Growing Use of Artificial Intelligence in Structural Heart
5.4 Future Trends
- 5.4.1 Technological Advancements in the Field of Structural Heart Devices
5.5 Impact analysis

6. North America Structural Heart Market -North America Analysis

6.1 North America Structural Heart Market Revenue Forecast and Analysis

7. North America Structural Heart Market - Revenue and Forecast to 2028 - by Product

7.1 Overview
7.2 North America Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
7.3 Occluders
- 7.3.1 Overview
- 7.3.2 Occluders: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Annuloplasty Rings
- 7.4.1 Overview
- 7.4.2 Annuloplasty Rings: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Heart Valve Balloons
- 7.5.1 Overview
- 7.5.2 Heart Valve Balloons: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Structural Heart Market - Revenue and Forecast to 2028 - by Procedure

8.1 Overview
8.2 North America Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
8.3 Heart Valve Stenosis
- 8.3.1 Overview
- 8.3.2 Heart Valve Stenosis: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Heart Valve Regurgitation
- 8.4.1 Overview
- 8.4.2 Heart Valve Regurgitation: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Left Atrial Appendage Closure
- 8.5.1 Overview
- 8.5.2 Left Atrial Appendage Closure: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Structural Heart Market - Revenue and Forecast to 2028 - by End User

9.1 Overview
9.2 North America Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Ambulatory Surgical Centers
- 9.4.1 Overview
- 9.4.2 Ambulatory Surgical Centers: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Cardiac Centers
- 9.5.1 Overview
- 9.5.2 Cardiac Centers: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Structural Heart Market - Revenue and Forecast to 2028 -Country Analysis

10.1 North America: North America Structural Heart Market
- 10.1.1 Overview
  - 10.1.1.1 United States: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 United States: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.3 United States: North America Structural Heart Market , by Product, 2019-2028 (US$ Million)
    - 10.1.1.1.4 United States: North America Structural Heart Market , by Procedure, 2019-2028 (US$ Million)
    - 10.1.1.1.5 United States: North America Structural Heart Market , by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
    - 10.1.1.1.6 United States: North America Structural Heart Market , by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
    - 10.1.1.1.7 United States: North America Structural Heart Market , by End User, 2019-2028 (US$ Million)
  - 10.1.1.2 Canada: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Canada: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.3 Canada: North America Structural Heart Market , by Product, 2019-2028 (US$ Million)
    - 10.1.1.2.4 Canada: North America Structural Heart Market , by Procedure, 2019-2028 (US$ Million)
    - 10.1.1.2.5 Canada: North America Structural Heart Market , by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
    - 10.1.1.2.6 Canada: North America Structural Heart Market , by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
    - 10.1.1.2.7 Canada: North America Structural Heart Market , by End User, 2019-2028 (US$ Million)
  - 10.1.1.3 Mexico: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Mexico: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.3 Mexico: North America Structural Heart Market , by Product, 2019-2028 (US$ Million)
    - 10.1.1.3.4 Mexico: North America Structural Heart Market , by Procedure, 2019-2028 (US$ Million)
    - 10.1.1.3.5 Mexico: North America Structural Heart Market , by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
    - 10.1.1.3.6 Mexico: North America Structural Heart Market , by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
    - 10.1.1.3.7 Mexico: North America Structural Heart Market , by End User, 2019-2028 (US$ Million)

11. North America Structural Heart Market -Industry Landscape

11.1 Overview
11.2 Growth Strategies
- 11.2.1 Overview

12. Company Profiles

12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Medtronic Plc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Boston Scientific Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Artivion Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Edwards Lifesciences Corp
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Lepu Medical Technology Beijing Co Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Braile Biomedica Industry, Commerce and Representations Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Micro Interventional Devices Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments

13. Appendix

13.1 About the Insight Partners
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Structural Heart Training Programs in the US
Table 2. United States North America Structural Heart Market , by Product - Revenue and Forecast to 2028 (US$ Million)
Table 3. United States North America Structural Heart Market , by Procedure - Revenue and Forecast to 2028 (US$ Million)
Table 4. United States North America Structural Heart Market , by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
Table 5. United States North America Structural Heart Market , by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
Table 6. United States North America Structural Heart Market , by End User - Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada North America Structural Heart Market , by Product - Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada North America Structural Heart Market , by Procedure - Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada North America Structural Heart Market , by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada North America Structural Heart Market , by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada North America Structural Heart Market , by End User - Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico North America Structural Heart Market , by Product - Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico North America Structural Heart Market , by Procedure - Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico North America Structural Heart Market , by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico North America Structural Heart Market , by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico North America Structural Heart Market , by End User - Revenue and Forecast to 2028 (US$ Million)
Table 17. Recent Organic Growth Strategies in North America Structural Heart Market
Table 18. Glossary of Terms

List Of Figures

Figure 1. North America Structural Heart Market Segmentation
Figure 2. North America Structural Heart Market , by Country
Figure 3. North America Structural Heart Market Overview
Figure 4. Occluders Segment Held Largest Share of Product Segment in North America Structural Heart Market
Figure 5. North America: PEST Analysis
Figure 6. North America Experts' Opinion
Figure 7. North America Structural Heart Market : Impact Analysis of Drivers and Restraints
Figure 8. North America Structural Heart Market - Revenue Forecast and Analysis - 2019-2028
Figure 9. North America Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
Figure 10. Occluders: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
Figure 11. Annuloplasty Rings: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Heart Valve Balloons: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
Figure 15. Heart Valve Stenosis: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Heart Valve Regurgitation: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Left Atrial Appendage Closure: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
Figure 19. Hospitals: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ambulatory Surgical Centers: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Cardiac Centers: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America: North America Structural Heart Market , by Key Country - Revenue (2021) (US$ Million)
Figure 23. North America: North America Structural Heart Market , by Country, 2021 & 2028 (%)
Figure 24. United States: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Canada: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Mexico: North America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)